The advent of the new revolutionary approach based on regenerative medicine is progressively reshaping the therapeutic scenario of many different diseases, such as cardiovascular diseases and immune diseases, with encouraging results. During the last 10 years, many studies have also proposed the use of mesenchymal stem cells (MSCs), adult stem cells with several interesting properties already used in different experimental models, for the treatment of diabetes, however, reporting conflicting outcomes. These reasons have given rise to a question: are these cells a real trump card for the biomedical field? Are they really able to outclass the traditional therapies, or at least able to give an advantage ove them? In this review, we will discuss the most promising results obtained with MSCs for the treatment of diabetes and its complications, we will compare the different therapeutic treatments applied as well as the most likely mechanisms of action, and overall we will give an in-depth overview of the pros and the cons of the use of MSCs for the therapy of both type-1 and type-2 diabetes.

Donzelli, E., Scuteri, A. (2020). Mesenchymal stem cells: A trump card for the treatment of diabetes?. BIOMEDICINES, 8(5) [10.3390/BIOMEDICINES8050112].

Mesenchymal stem cells: A trump card for the treatment of diabetes?

Donzelli E.
Co-ultimo
;
Scuteri A.
Co-ultimo
2020

Abstract

The advent of the new revolutionary approach based on regenerative medicine is progressively reshaping the therapeutic scenario of many different diseases, such as cardiovascular diseases and immune diseases, with encouraging results. During the last 10 years, many studies have also proposed the use of mesenchymal stem cells (MSCs), adult stem cells with several interesting properties already used in different experimental models, for the treatment of diabetes, however, reporting conflicting outcomes. These reasons have given rise to a question: are these cells a real trump card for the biomedical field? Are they really able to outclass the traditional therapies, or at least able to give an advantage ove them? In this review, we will discuss the most promising results obtained with MSCs for the treatment of diabetes and its complications, we will compare the different therapeutic treatments applied as well as the most likely mechanisms of action, and overall we will give an in-depth overview of the pros and the cons of the use of MSCs for the therapy of both type-1 and type-2 diabetes.
Articolo in rivista - Review Essay
Immune suppression; Insulin; Mesenchymal stem cells; Pancreatic islets transplantation; Type-1 diabetes; Type-2 diabetes;
English
6-mag-2020
2020
8
5
112
open
Donzelli, E., Scuteri, A. (2020). Mesenchymal stem cells: A trump card for the treatment of diabetes?. BIOMEDICINES, 8(5) [10.3390/BIOMEDICINES8050112].
File in questo prodotto:
File Dimensione Formato  
Donzelli-2020-Biomedicines-VoR.pdf

accesso aperto

Descrizione: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 465.31 kB
Formato Adobe PDF
465.31 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/293294
Citazioni
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 4
Social impact